ONK Therapeutics

ONK Therapeutics

Biotechnology Research Galway, Ie 17 employees
Employees
17
Contacts
3
Emails
3
Phones
2

ONK Therapeutics Overview

Headquarters
Galway, Ie
Industry
Biotechnology Research
Employees
17
Founded
2015
Funding
21.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ONK Therapeutics

ONK Therapeutics, is an innovative cell therapy company dedicated to developing a next generation of off-the-shelf, dual-targeted NK cell therapy platform targeting hematological malignancies and solid tumors. The Company was founded in 2015, by Prof. O’Dwyer MD, of NUI Galway, an expert in translational multiple myeloma research, the tumour microenvironment, and exploitation of NK cells as cellular immunotherapy. Its core proprietary platform is based on a dual-targeted NK cell expressing both a chimeric antigen receptor (CAR) targeting a known tumour antigen and a TNF related apoptosis inducing ligand variant (TRAILv) targeting the death receptor pathway (i.e. DR4 or DR5). This promising new approach has the potential to enhance efficacy by addressing both intrinsic (e.g. CAR engagement of a tumor specific antigen) and extrinsic (e.g. signalling through the death receptor pathway) apoptotic pathways, and to reduce the susceptibility to possible target antigen escape through the engagement of tumor antigen independent TRAILv.

ONK Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

ONK Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Tony K. Founder & Director of Killarney
View
Chris Nowers Executive Leader - Builds Cohesive
Email Phone
Leigh Ann Peeleman
Email
George Schlich Director, Schlich Limited; Board
Email Phone

Employees by Management Level

Individual contributor 3 profiles
Executive 1 profile
Director 1 profile
Manager 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Compare Similar Companies to ONK Therapeutics